Katharine Knobil's Net Worth
$0
Who is Katharine Knobil?
Katharine Knobil does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Kaleido Biosciences, Inc., ARENA PHARMACEUTICALS INC, Marker Therapeutics, Inc., PLIANT THERAPEUTICS, INC., and Korro Bio, Inc..
SEC CIK
Katharine Knobil's CIK is 0001768011
Past Insider Trading and Trends
2020 was Katharine Knobil's most active year for acquiring shares with 7 total transactions. Katharine Knobil's most active month to acquire stocks was the month of May. 2022 was Katharine Knobil's most active year for disposing of shares, totalling 5 transactions. Katharine Knobil's most active month to dispose stocks was the month of February. 2021 saw Katharine Knobil paying a total of $0.00 for 135,269 shares, this is the most they've acquired in one year. In 2022 Katharine Knobil cashed out on 21,523 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARENA PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.82K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
| +81.70% | 3.07K |
—
|
—
| 6.82K |
Jun 11
| |||
Form 4
| +4,316.47% | 3.67K |
—
|
—
| 3.75K |
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Marker Therapeutics, Inc. (MRKR) Snapshot price: $3.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $12.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Korro Bio, Inc. (KRRO) Snapshot price: $42.73
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||